Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleta Pupovac

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|September 5, 2022
CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategiesVan To, Vera J Evtimov, Graham Jenkin, et al.
Immunological Investigations|August 1, 2025
Engineering TAG-72 and CD30 CAR-T Cells for T Cell MalignanciesVan To, Vera J Evtimov, Runzhe Shu, et al.
Biochimica Et Biophysica Acta|July 22, 2010
P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cellsAndrew W Farrell, Safina Gadeock, Aleta Pupovac, et al.
Experimental Dermatology|February 2, 2010
Murine epidermal Langerhans cells and keratinocytes express functional P2X7 receptorsJimmy N S N Tran, Aleta Pupovac, Rosanne M Taylor, et al.
Journal of Innate Immunity|May 23, 2015
Group A Streptococcus Modulates Host Inflammation by Manipulating Polymorphonuclear Leukocyte Cell Death ResponsesJames A Tsatsaronis, Diane Ly, Aleta Pupovac, et al.
Molecular Therapy Oncolytics|February 22, 2021
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancerRunzhe Shu, Vera J Evtimov, Maree V Hammett, et al.
Molecular Therapy. Oncology|April 10, 2025
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancerVera J Evtimov, Nhu-Y N Nguyen, Maree V Hammett, et al.
Heliyon|September 12, 2024
Targeting TAG-72 in cutaneous T cell lymphomaVera J Evtimov, Maree V Hammett, Aleta Pupovac, et al.
Bioengineering & Translational Medicine|November 29, 2023
Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapyRunzhe Shu, Maree Hammett, Vera Evtimov, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|September 5, 2022
CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategiesVan To, Vera J Evtimov, Graham Jenkin, et al.
Immunological Investigations|August 1, 2025
Engineering TAG-72 and CD30 CAR-T Cells for T Cell MalignanciesVan To, Vera J Evtimov, Runzhe Shu, et al.
Biochimica Et Biophysica Acta|July 22, 2010
P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cellsAndrew W Farrell, Safina Gadeock, Aleta Pupovac, et al.
Experimental Dermatology|February 2, 2010
Murine epidermal Langerhans cells and keratinocytes express functional P2X7 receptorsJimmy N S N Tran, Aleta Pupovac, Rosanne M Taylor, et al.
Journal of Innate Immunity|May 23, 2015
Group A Streptococcus Modulates Host Inflammation by Manipulating Polymorphonuclear Leukocyte Cell Death ResponsesJames A Tsatsaronis, Diane Ly, Aleta Pupovac, et al.
Molecular Therapy Oncolytics|February 22, 2021
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancerRunzhe Shu, Vera J Evtimov, Maree V Hammett, et al.
Molecular Therapy. Oncology|April 10, 2025
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancerVera J Evtimov, Nhu-Y N Nguyen, Maree V Hammett, et al.
Heliyon|September 12, 2024
Targeting TAG-72 in cutaneous T cell lymphomaVera J Evtimov, Maree V Hammett, Aleta Pupovac, et al.
Bioengineering & Translational Medicine|November 29, 2023
Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapyRunzhe Shu, Maree Hammett, Vera Evtimov, et al.
Pageof 2